99 related articles for article (PubMed ID: 6690011)
21. Correlation of hypercupremia with other acute phase reactants in malignant lymphoma.
Shah I; Lewkow LM; Khilanani U
Cancer; 1983 Mar; 51(5):851-4. PubMed ID: 6401595
[TBL] [Abstract][Full Text] [Related]
22. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
Asbjörnsen G
Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
[TBL] [Abstract][Full Text] [Related]
23. Results of combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
[TBL] [Abstract][Full Text] [Related]
24. Copper and zinc levels in serum from human patients with sarcomas.
Fisher GL; Byers VS; Shifrine M; Levin AS
Cancer; 1976 Jan; 37(1):356-63. PubMed ID: 764964
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
Casamassima A; Addabbo L; Caporusso L; Lorusso V
Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
[TBL] [Abstract][Full Text] [Related]
26. [Gastric lymphomas and pseudolymphomas].
Chabloz R; Givel JC; Saraga P; Saegesser F
Helv Chir Acta; 1980 Dec; 47(5):547-53. PubMed ID: 7204076
[TBL] [Abstract][Full Text] [Related]
27. Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma.
Shah I; Chou T; Tapazoglou E; Kessel D
Scand J Haematol; 1984 Mar; 32(3):332-4. PubMed ID: 6701469
[TBL] [Abstract][Full Text] [Related]
28. Serum beta 2-microglobulin in malignant lymphoma.
Hagberg H; Killander A; Simonsson B
Cancer; 1983 Jun; 51(12):2220-5. PubMed ID: 6189572
[TBL] [Abstract][Full Text] [Related]
29. Combined modality therapy in malignant lymphomas.
Glatein E; Donaldson SS; Rosenberg SA; Kaplan HS
Cancer Treat Rep; 1977 Sep; 61(6):1199-207. PubMed ID: 332354
[TBL] [Abstract][Full Text] [Related]
30. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
31. A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Tirelli U; Carbone A; Crivellari D; Volpe R; Franchin G; Veronesi A; Galligioni E; Trovò M; Tumolo S; Grigoletto E
Cancer; 1984 Aug; 54(3):393-6. PubMed ID: 6375853
[TBL] [Abstract][Full Text] [Related]
32. Rosette and blastogenesis inhibition by plasma from Hodgkin's disease and other malignancies. Positive correlation in State I and II Hodgkin's disease.
Sinclair T; Ezdinli EZ; Boonlayangoor P; Wasser LP; Han T
Cancer; 1983 Jan; 51(2):238-44. PubMed ID: 6336976
[TBL] [Abstract][Full Text] [Related]
33. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
34. [Serum levels of copper and zinc in patients with lung cancer].
Altavilla G; Adamo V; Alafaci E; Buemi B; Chillemi S; La Scala R; Marabello G; Palmara D
Minerva Med; 1985 Nov; 76(44):2117-20. PubMed ID: 4069424
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?
Johnson GJ; Oken MM; Anderson JR; O'Connell MJ; Glick JH
Lancet; 1984 Sep; 2(8404):685-7. PubMed ID: 6147703
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
39. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; De Souza C; Aversa S; Patti C; Tedeschi L; Candela M; Olivieri A; Chisesi T; Rubagotti A; Centurioni R; Nardi V; Congiu M; Gennaro M; Truini M;
Braz J Med Biol Res; 2004 May; 37(5):719-28. PubMed ID: 15107935
[TBL] [Abstract][Full Text] [Related]
40. Histopathologic review of lymphoma cases from the Southwest Oncology Group.
Jones SE; Butler JJ; Byrne GE; Coltman CA; Moon TE
Cancer; 1977 Mar; 39(3):1071-6. PubMed ID: 334362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
